Corline Biomedical AB

Informe acción OM:CLBIO

Capitalización de mercado: SEK 138.0m

Corline Biomedical Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Henrik Nittmar

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO16.8yrs
Participación del CEO2.9%
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directiva7.8yrs

Actualizaciones recientes de la dirección

Recent updates

Corline Biomedical (STO:CLBIO) Is In A Strong Position To Grow Its Business

Aug 24
Corline Biomedical (STO:CLBIO) Is In A Strong Position To Grow Its Business

We Think Corline Biomedical (STO:CLBIO) Can Afford To Drive Business Growth

Mar 15
We Think Corline Biomedical (STO:CLBIO) Can Afford To Drive Business Growth

We're Interested To See How Corline Biomedical (STO:CLBIO) Uses Its Cash Hoard To Grow

Nov 26
We're Interested To See How Corline Biomedical (STO:CLBIO) Uses Its Cash Hoard To Grow

Corline Biomedical (STO:CLBIO) Is In A Strong Position To Grow Its Business

Jun 22
Corline Biomedical (STO:CLBIO) Is In A Strong Position To Grow Its Business

We Think Corline Biomedical (STO:CLBIO) Can Easily Afford To Drive Business Growth

Feb 16
We Think Corline Biomedical (STO:CLBIO) Can Easily Afford To Drive Business Growth

Companies Like Corline Biomedical (STO:CLBIO) Are In A Position To Invest In Growth

Jun 14
Companies Like Corline Biomedical (STO:CLBIO) Are In A Position To Invest In Growth

Here's Why We're Watching Corline Biomedical's (STO:CLBIO) Cash Burn Situation

Feb 28
Here's Why We're Watching Corline Biomedical's (STO:CLBIO) Cash Burn Situation

CEO

Henrik Nittmar (58 yo)

16.8yrs

Permanencia

Dr. Henrik Nittmar, Ph. D., has been the Chief Executive Officer of Corline Biomedical AB (publ) (alternate name Corline Systems AB) since 2008. Dr. Nittmar works as an Investment Manager for a select numb...

Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Thomas Lifvendahl
Non-Executive Director2.8yrssin datossin datos
Lars Sunnanväder
Non-Executive Director19.8yrssin datos9.82%
SEK 13.5m
Gunilla Ekstrom
Independent Non-Executive Director7.8yrsSEK 105.00ksin datos
Adam Dahlberg
Chairman19.8yrssin datos28.23%
SEK 39.0m
Henrik Krook
Independent Non-Executive Director7.5yrsSEK 105.00ksin datos
Rutger Ploeg
Scientific Advisor7.8yrssin datossin datos
Magnus Nilsson
Independent Non-Executive Director4.8yrssin datossin datos

7.8yrs

Permanencia media

53.5yo

Promedio de edad

Junta con experiencia: La junta directiva de CLBIO se considera experimentada (7.8 años de antigüedad promedio).